Data Collective Iv Gp, LLC Roivant Sciences Ltd. Transaction History
Data Collective Iv Gp, LLC
- $90.5 Million
- Q2 2025
A detailed history of Data Collective Iv Gp, LLC transactions in Roivant Sciences Ltd. stock. As of the latest transaction made, Data Collective Iv Gp, LLC holds 3,875 shares of ROIV stock, worth $44,833. This represents 0.05% of its overall portfolio holdings.
Number of Shares
3,875
Previous 3,875
-0.0%
Holding current value
$44,833
Previous $39,000
10.26%
% of portfolio
0.05%
Previous 0.05%
Shares
2 transactions
Others Institutions Holding ROIV
# of Institutions
360Shares Held
447MCall Options Held
8.17MPut Options Held
725K-
Sb Investment Advisers (Uk) LTD London, X060MShares$694 Million5.36% of portfolio
-
Vanguard Group Inc Valley Forge, PA39.3MShares$455 Million0.01% of portfolio
-
Morgan Stanley New York, NY35.9MShares$416 Million0.03% of portfolio
-
Black Rock Inc. New York, NY35.4MShares$409 Million0.01% of portfolio
-
Viking Global Investors LP34.2MShares$396 Million1.22% of portfolio
About Roivant Sciences Ltd.
- Ticker ROIV
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 704,382,976
- Market Cap $8.15B
- Description
- Roivant Sciences Ltd., a biopharmaceutical and healthcare technology company that researches and develops medicines. The company develops product candidates for the treatment of various therapeutics, including solid tumors, sickle cell diseases, hypophosphatasia, oncologic malignancies, psoriasis, atopic dermatitis, vitiligo, hyperhidrosis, acne...